Phytosphingosine Salicyloyl
76 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
76
Total Reports
0
Deaths Reported
0.0%
Death Rate
Active Ingredients
Phytosphingosine Salicyloyl
Administration Routes
TopicalAuricular (Otic)Oral
Species Affected
Dog 63
Cat 12
Human 1
Most Affected Breeds
Crossbred Canine/dog 12
Domestic Shorthair 9
Mixed (Dog) 8
Retriever - Labrador 6
Dog (unknown) 4
Shepherd Dog - German 3
Terrier - Boston 3
Dachshund - Miniature 3
Boxer (German Boxer) 2
Maltese 2
Most Reported Reactions
Application site erythema 21
Application site irritation 7
Application site pruritus 7
Lack of efficacy - NOS 7
Application site reddening 5
Pruritus 3
Other abnormal test result NOS 3
Behavioural disorder NOS 3
Swollen eye 3
Hives (see also 'Skin') 3
Application site inflammation 3
Eye redness 2
Outcome Breakdown
Recovered/Normal
39 (51.3%)
Ongoing
23 (30.3%)
Outcome Unknown
13 (17.1%)
Recovered with Sequela
1 (1.3%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.